Cargando…
Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands
BACKGROUND: The Open Targets Platform integrates different data sources in order to facilitate identification of potential therapeutic drug targets to treat human diseases. It currently provides evidence for nearly 2.6 million potential target-disease pairs. G-protein coupled receptors are a drug ta...
Autores principales: | Freudenberg, Johannes M, Dunham, Ian, Sanseau, Philippe, Rajpal, Deepak K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167889/ https://www.ncbi.nlm.nih.gov/pubmed/30285606 http://dx.doi.org/10.1186/s12859-018-2392-y |
Ejemplares similares
-
Significant obesity‐associated gene expression changes occur in the stomach but not intestines in obese mice
por: Chen, Jing, et al.
Publicado: (2016) -
In silico prediction of novel therapeutic targets using gene–disease association data
por: Ferrero, Enrico, et al.
Publicado: (2017) -
Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands targeting G-protein-coupled receptors
por: Akhunzada, Muhammad Jan, et al.
Publicado: (2022) -
Receptor component protein, an endogenous allosteric modulator of family B G protein coupled receptors
por: Routledge, Sarah J., et al.
Publicado: (2020) -
Activation of a G protein-coupled receptor by its endogenous ligand triggers the Caenorhabditis elegans innate immune response
por: Zugasti, Olivier, et al.
Publicado: (2014)